secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vicarious Surgical Inc. (RBOT)
CIK:        0001812173
Form:       8-K
Filed at:   2025-03-13T23:59:59+00:00
Accession:  0001213900-25-023441
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Vicarious Surgical Appoints Sarah Romano as CFO Effective April 1, 2025
-----------------------------------------------------------------------

- Sarah Romano named CFO and Treasurer, effective April 1, 2025; succeeds prior CFO? Not disclosed.
- Base salary $435,000; target annual bonus 40%; receives stock option for 55,000 shares with 25% vesting at 1 year.
- Romano previously CFO of Entero Therapeutics (Nasdaq: ENTO) and Kiora Pharmaceuticals (Nasdaq: KPRX).
- Press release cites approaching first clinical use cases in 2025 as key milestone for financial strategy.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1812173/000121390025023441/0001213900-25-023441-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1812173/000121390025023441/ea0234154-8k_vicarious.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-023441

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer